Form 8-K - Current report:
SEC Accession No. 0000950170-23-029499
Filing Date
2023-06-23
Accepted
2023-06-23 07:05:14
Documents
14
Period of Report
2023-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grph-20230623.htm   iXBRL 8-K 59737
2 EX-99.1 grph-ex99_1.htm EX-99.1 14772
3 GRAPHIC img1455458_0.jpg GRAPHIC 4727
  Complete submission text file 0000950170-23-029499.txt   206352

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20230623_pre.xml EX-101.PRE 10228
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20230623.xsd EX-101.SCH 2466
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20230623_lab.xml EX-101.LAB 13904
8 EXTRACTED XBRL INSTANCE DOCUMENT grph-20230623_htm.xml XML 4860
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 231034858
SIC: 2836 Biological Products, (No Diagnostic Substances)